Company Filing History:
Years Active: 2000-2002
Title: Inventor Spotlight: Robert H. Stoffel
Introduction
Robert H. Stoffel is an accomplished inventor based in Hamden, Connecticut, known for his significant contributions to the field of pharmacology. With two patents to his name, Stoffel has made strides in developing innovative compounds aimed at addressing critical health issues, particularly in the realm of appetite regulation and weight loss.
Latest Patents
Stoffel's latest patents focus on two primary innovations: "NPY antagonists: spiroisoquinolinone derivatives" and "Imidazolone anorectic agents: II. phenyl derivatives." These patents detail a series of non-peptidergic antagonists of Neuropeptide Y (NPY), synthesized as phenyl derivatives of imidazolone compounds. As antagonists of NPY-induced feeding behavior, these innovative compounds are expected to serve as effective anorexiant agents, aiding in weight loss and treatment of eating disorders.
Career Highlights
Stoffel is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical firm. His work at the company has centered around the development of groundbreaking treatments that address various health conditions. With his focus on pharmacological innovations, Stoffel has been instrumental in advancing new therapeutic approaches that could benefit countless individuals struggling with eating disorders.
Collaborations
Throughout his career, Robert H. Stoffel has collaborated with various esteemed colleagues, including Graham S. Poindexter and Ildiko Antal. These partnerships have fostered a dynamic research environment that emphasizes innovation and the pursuit of effective solutions to complex medical challenges.
Conclusion
Robert H. Stoffel exemplifies the spirit of innovation in the pharmacological landscape. Through his development of NPY antagonists and imidazolone anorectic agents, he continues to contribute valuable advancements that may revolutionize approaches to weight loss and eating disorder treatment in the future. His commitment to research and collaboration stands as a testament to the potential impact of dedicated inventors in the medical field.